Chimie physique générale, Chimie thérapeutique Bertrand RIHN ................................... Biochimie ,
Chimie thérapeutique Chimie thérapeutique ,
Chimie thérapeutique, Microbiologie clinique Béatrice FAIVRE ??????????????..Hématologie -Génie Biologique ,
Hématologie biologique ,
Biophysique ,
Pharmacie galénique PROFESSEUR ASSOCIE, Biochimie et Biologie ,
Anglais Bibliothèque Universitaire Santé -Lionnois (Pharmacie -Odontologie) 5 ,
Pour 1 des patients le taux d'hémoglobine était supérieur à 11 g/dl. Pour les 3 autres patients, le taux d'hémoglobine est compris entre 9,5 et 10, Au nadir le taux moyen d'hémoglobine du groupe témoin était de 10 ,
Les 4 patients avaient un taux de plaquettes supérieur à 100 G/l. Au nadir de cette cure, le taux moyen de plaquettes était de 125 ,
Au nadir elle n'a été évaluée que pour 1 des patients, Sa créatininémie était de 6 ,
Malignancy after Transplantation, Transplantation, vol.80, issue.Supplement, pp.254-64, 2005. ,
DOI : 10.1097/01.tp.0000186382.81130.ba
Tumeurs solides apr??s transplantation r??nale, N??phrologie & Th??rapeutique, vol.4, pp.214-217, 2008. ,
DOI : 10.1016/S1769-7255(08)74238-X
???Will all liver transplantation patients eventually die from cancer????, Journal of Hepatology, vol.44, issue.1, pp.13-18, 2006. ,
DOI : 10.1016/j.jhep.2005.10.007
Comparison of the Incidence of De Novo Solid Malignancies After Heart Transplantation to That in the General Population, The American Journal of Cardiology, vol.103, issue.4, pp.562-568, 2009. ,
DOI : 10.1016/j.amjcard.2008.10.026
Lung Cancer After Heart Transplantation: A 17-Year Experience, The Annals of Thoracic Surgery, vol.79, issue.3, pp.980-83, 2005. ,
DOI : 10.1016/j.athoracsur.2004.05.021
DE NOVO MALIGNANCIES AFTER INTESTINAL AND MULTIVISCERAL TRANSPLANTATION, Transplantation, vol.77, issue.11, pp.1719-1744, 2004. ,
DOI : 10.1097/01.TP.0000131164.43015.4B
URL : http://pdfs.journals.lww.com/transplantjournal/2004/06150/DE_NOVO_MALIGNANCIES_AFTER_INTESTINAL_AND.16.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1505121305216;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdGlb2qsojlvlytk14LkMXSMx6m5WuzE4AjoVkUM/iVHiDpEI1gRY87mf+RA54S84y;hash|X+bEb9LovI3Duj90s+1WtQ==
PRO- AND ANTI-CANCER EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED IN ORGAN TRANSPLANTATION, Transplantation, vol.77, issue.12, pp.1777-82, 2004. ,
DOI : 10.1097/01.TP.0000120181.89206.54
Malignancies in renal transplantation: an unmet medical need, Nephrology Dialysis Transplantation, vol.22, issue.Supplement 1 ,
DOI : 10.1093/ndt/gfm085
Management of solid tumours in organ-transplant recipients, The Lancet Oncology, vol.8, issue.10, pp.921-953, 2007. ,
DOI : 10.1016/S1470-2045(07)70315-7
Cancers after renal transplantation, Transplantation Reviews, vol.22, issue.2, pp.141-150, 2008. ,
DOI : 10.1016/j.trre.2007.12.004
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance, Nephrology Dialysis Transplantation, vol.22, issue.Supplement 1, pp.36-41, 2007. ,
DOI : 10.1093/ndt/gfm090
Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies, Transplantation, vol.80, issue.7, pp.883-892, 2005. ,
DOI : 10.1097/01.TP.0000184006.43152.8D
Annual Report to the Nation on the Status of Cancer, 1975???2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control, JNCI: Journal of the National Cancer Institute, vol.299, issue.11, pp.1672-1694, 1975. ,
DOI : 10.1001/jama.299.11.1351
Mortalité par type de cancer Données disponibles à : http://www.igr.fr/index.php?p_id=84, Consulté le 05 Juillet, 2010. ,
The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends, Journal of Thoracic Oncology, vol.3, issue.8, pp.819-831, 2008. ,
DOI : 10.1097/JTO.0b013e31818020eb
Epidemiology of lung cancer : ACCP evidence-based clinical practice guidelines, Chest, vol.2132, pp.29-55, 2007. ,
Les cancers intrathoraciques. Collection oncologie pratique ,
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today, JNCI: Journal of the National Cancer Institute, vol.66, issue.6, pp.1191-1308, 1981. ,
DOI : 10.1093/jnci/66.6.1192
Lung cancer and passive smoking, International Journal of Cancer, vol.302, issue.1, pp.1-4, 1981. ,
DOI : 10.1002/ijc.2910270102
Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study, Environmental Health, vol.58, issue.12, p.7, 2007. ,
DOI : 10.1136/thorax.58.12.1071
Environmental Tobacco Smoke and Lung Cancer, Epidemiology, vol.9, issue.6, pp.672-675, 1998. ,
DOI : 10.1097/00001648-199811000-00020
Familial Risk of Lung Cancer among Nonsmokers and Their Relatives, American Journal of Epidemiology, vol.144, issue.6, pp.554-562, 1996. ,
DOI : 10.1093/oxfordjournals.aje.a008965
Lung Cancer Attributable to Indoor Radon Exposure in France: Impact of the Risk Models and Uncertainty Analysis, Environmental Health Perspectives, vol.114, issue.9, pp.1361-1366, 2006. ,
DOI : 10.1289/ehp.9070
URL : https://hal.archives-ouvertes.fr/inserm-00138827
Outdoor air pollution and lung cancer: Recent epidemiologic evidence, International Journal of Cancer, vol.54, issue.5, pp.647-653, 2004. ,
DOI : 10.1016/S0027-5107(97)00097-3
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.20292/pdf
Respiratory cancer and exposure to arsenic, chromium, nickel, and polycyclic aromatic hydrocarbons, Clinics in Occupational and Environmental Medicine, vol.2, issue.4, pp.779-801, 2002. ,
DOI : 10.1016/S1526-0046(02)00056-0
Genetic Predisposition to Lung Cancer, Chest, vol.125, issue.5, pp.86-89, 2004. ,
DOI : 10.1378/chest.125.5_suppl.86S
Systematic review of the relationship between family history and lung cancer risk, British Journal of Cancer, vol.27, issue.Suppl 1, pp.825-833, 2005. ,
DOI : 10.1093/jjco/27.6.415
A Major Lung Cancer Susceptibility Locus Maps to Chromosome 6q23???25, The American Journal of Human Genetics, vol.75, issue.3, pp.460-74, 2004. ,
DOI : 10.1086/423857
A meta-analysis of asthma and risk of lung cancer (United States), Cancer Causes and Control, vol.14, issue.4, pp.327-334, 2003. ,
DOI : 10.1023/A:1023982402137
La classification anatomopatologique des cancers bronchopulmonaires, Rev Mal Respir Actual, vol.1, pp.280-291, 2009. ,
DOI : 10.1016/s1877-1203(09)72496-6
World Health Organisation classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and hear, 2004. ,
Cancer bronchique et facteurs de risque : existe-t-il des marqueurs phénotypiques spécifiques ? Thèse Université Henri Poincaré, 2009. ,
La nouvelle classification TNM du cancer bronchqiue, Rev Mal Respir, vol.25, pp.3-40, 2008. ,
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer, Journal of Thoracic Oncology, vol.2, issue.7, pp.593-602, 2007. ,
DOI : 10.1097/JTO.0b013e31807a2f81
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer, Journal of Thoracic Oncology, vol.2, issue.12, pp.1067-77, 2007. ,
DOI : 10.1097/JTO.0b013e31815bdc0d
Cancer bronchique non à petites cellules (version du 20 Août, 2009. ,
Diagnosis and management of lung cancer executive summary. ACCP Evidence-based clinical practice guideline, Chest, vol.2, issue.132, pp.1-19, 2007. ,
Formes cliniques des cancers thoraciques. Traitement des tumeurs de Pancoast-Tobias, Rev Mal Respir, vol.23, pp.16-164, 2006. ,
Induction Chemoradiation and Surgical Resection for Superior Sulcus Non???Small-Cell Lung Carcinomas: Long-Term Results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160), Journal of Clinical Oncology, vol.25, issue.3, pp.313-318, 2007. ,
DOI : 10.1200/JCO.2006.08.2826
Prise en charge du cancer bronchique ?? petites cellules (CPC) (localis?? et ??tendu), Revue des Maladies Respiratoires Actualit??s, vol.1, issue.4, 2009. ,
DOI : 10.1016/S1877-1203(09)72517-0
Systematic Review Evaluating the Timing of Thoracic Radiation Therapy in Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.22, issue.23, pp.4837-4882, 2004. ,
DOI : 10.1200/JCO.2004.01.178
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study, The Lancet Oncology, vol.11, issue.6, pp.521-530, 2010. ,
DOI : 10.1016/S1470-2045(10)70112-1
Quel traitement en deuxi??me ligne m??tastatique des cancers bronchiques non ?? petites cellules ?, Revue des Maladies Respiratoires Actualit??s, vol.1, issue.4, pp.415-420, 2009. ,
DOI : 10.1016/S1877-1203(09)72514-5
Local failure after complete resection of N0-1 non-small cell lung cancer, Lung Cancer, 2010. ,
Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial, Lung Cancer, vol.43, issue.2, pp.183-94, 2004. ,
DOI : 10.1016/j.lungcan.2003.09.001
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced nonsmall-cell lung cancer previously treated with platinum-containing chemotherapy regimens ,
Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.25, issue.11, pp.1377-82, 2007. ,
DOI : 10.1200/JCO.2006.09.8251
Erlotinib in Previously Treated Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.353, issue.2, pp.123-155, 2005. ,
DOI : 10.1056/NEJMoa050753
First-line chemotherapy rechallenge after relapse in small cell lung cancer, Cancer Chemotherapy and Pharmacology, vol.21, issue.1, pp.45-53, 1988. ,
DOI : 10.1007/BF00262737
Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.25, issue.15, pp.2086-92, 2007. ,
DOI : 10.1200/JCO.2006.08.3998
Hepatotoxicity of Chemotherapy, The Oncologist, vol.6, issue.2, pp.162-176, 2001. ,
DOI : 10.1634/theoncologist.6-2-162
Toxicit?? des chimioth??rapies en canc??rologie pulmonaire, EMC - Pneumologie, vol.3, issue.3, pp.6-8, 2006. ,
DOI : 10.1016/S1155-195X(06)44070-6
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours, European Journal of Cancer, vol.42, issue.15, pp.2433-53, 2006. ,
DOI : 10.1016/j.ejca.2006.05.002
update on EORTC guidelines and anemia management with erythropoiesis-stimulating agent. The Oncologist, pp.33-36, 2007. ,
Prise en charge des nausées et vomissements en oncologie thoracique. Revue de Pneumologie clinique, pp.76-80, 2008. ,
Connaître, comprendre et prévenir les effets secondaires des sels de platine. La lettre du cancérologue, pp.225-234, 1993. ,
Hydratation des patients sous cisplatine : enqu??te de pratiques et ??laboration d???un protocole, Th??rapie, vol.60, issue.5, pp.499-505, 2006. ,
DOI : 10.2515/therapie:2005071
Hemolytic remic syndrome associated with gemcitabine : a case report and a review of literature, J Pancreas, vol.6, pp.369-74, 2005. ,
Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study, Annals of Oncology, vol.12, issue.7, pp.957-62, 2001. ,
DOI : 10.1023/A:1011171722175
Preventing Paclitaxel-Induced Peripheral Neuropathy: A Phase II Trial of Vitamin E Supplementation, Journal of Pain and Symptom Management, vol.32, issue.3, pp.237-244, 2006. ,
DOI : 10.1016/j.jpainsymman.2006.03.013
Suivi du patient après transplantation cardiaque, monitoring et adaptation de l'immunosuppression, 2009. ,
Transplantation immunology: Solid organ and bone marrow, Journal of Allergy and Clinical Immunology, vol.125, issue.2, pp.324-335, 2010. ,
DOI : 10.1016/j.jaci.2009.11.014
URL : http://europepmc.org/articles/pmc2857984?pdf=render
Steroïd avoidance or withdrawal for kidney transplant recipient, Ann Intern Med, vol.15, pp.3-11, 2009. ,
Mycophenolic acid formulations in adult renal transplantation. Update on efficacy and tolerability, Ther Clin Risk Manag, vol.5, pp.341-351, 2009. ,
The Natural History of Chronic Allograft Nephropathy, New England Journal of Medicine, vol.349, issue.24, pp.2326-2359, 2003. ,
DOI : 10.1056/NEJMoa020009
Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The 'Reference' Study, American Journal of Transplantation, vol.15, issue.11, pp.2725-2759, 2006. ,
DOI : 10.1046/j.1600-6143.2005.00779.x
URL : https://hal.archives-ouvertes.fr/inserm-00473412
Evaluation of the efficacy and safety of a slow conversion from a calcineurine inhibitor-to sirolimus based therapies in maintenance renal-transplant patient presenting with moderate renal insufficiency, Transplant Int, vol.20, pp.2517-2540, 2007. ,
Reduced exposure to calcineurine inhibitors in renal transplantation, The New England Journal of Medecine, vol.357, pp.2562-75, 2007. ,
Costimulatory blockade with belatacept in clinical and experimental transplantation ??? a review, Expert Opinion on Biological Therapy, vol.8, issue.6, pp.789-96, 2009. ,
DOI : 10.1097/01.tp.0000332144.71847.97
Surveillance biologique des patients transplant??s r??naux??: vers une pr??vision des complications associ??es ?? l???immunosuppression???, Annales Pharmaceutiques Fran??aises, vol.66, issue.2, pp.115-121, 2008. ,
DOI : 10.1016/j.pharma.2008.03.004
Base de données Hépatox Données disponibles à http, 2010. ,
mTOR inhibitors and their secondary effect in cardiac transplant recipients : a descriptive study ,
Principaux chiffres nationaux Données accessibles à, Mise à jour du 25, 2009. ,
Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report???2009, The Journal of Heart and Lung Transplantation, vol.28, issue.10, pp.1007-1029, 2009. ,
DOI : 10.1016/j.healun.2009.08.014
Impact of different long-term maintenance immunosuppressive therapy strategies on patients' outcome after heart transplantation, Transplant Immunology, vol.23, issue.3, pp.93-103, 2010. ,
DOI : 10.1016/j.trim.2010.04.007
Updates in Heart Transplantation, Transplantation Proceedings, vol.40, issue.8 ,
DOI : 10.1016/j.transproceed.2008.07.112
Transplantation r??nale: indications, r??sultats, limites et??perspectives, La Presse M??dicale, vol.36, issue.12, pp.1829-1863, 2007. ,
DOI : 10.1016/j.lpm.2007.04.037
Bilan des activitésde greffes et de prélèvements Données disponibles à : http://www.agence-biomedecine.fr/annexes, 2008. ,
Synthèse des recommandations professionnelles. Suivi ambulatoire de l'adulte transplanté rénal au-delà de 3 mois après transplantation, 2007. ,
Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine???sirolimus interaction, Kidney International, vol.70, issue.6, pp.1019-1025, 2006. ,
DOI : 10.1038/sj.ki.5001649
La glycoprotéine P : un transporteur de médicaments à ne pas négliger, Revue Médicale Suisse, vol.524, 2004. ,
Cisplatin-Based Chemotherapy in a Renal Transplant Recipient with Metastatic Germ Cell Testicular Cancer, Acta Oncologica, vol.73, issue.6, pp.759-61, 1996. ,
DOI : 10.1002/1097-0142(19940101)73:1<196::AID-CNCR2820730134>3.0.CO;2-F
Drug Interactions with Commonly used Immunosuppressive Agents ,
DOI : 10.1002/9780470751541.ch30
Medical care of the liver transplant patient : total pre-, intraand post-operative management, Massachussetts. Blackwell Science Inc, pp.522-557, 2006. ,
DOI : 10.1002/9780470751541
Gender, Histology, and Time of Diagnosis Are Important Factors for Prognosis: Analysis of 1499 Never-Smokers with Advanced Non-small Cell Lung Cancer in Japan, Journal of Thoracic Oncology, vol.5, issue.7, pp.1011-1018, 2010. ,
DOI : 10.1097/JTO.0b013e3181dc213e
Lung Cancer in Transplant Recipients, Archives of Surgery, vol.139, issue.8, pp.902-906, 2004. ,
DOI : 10.1001/archsurg.139.8.902
Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: A case series, Liver Transplantation, vol.12, issue.6, pp.634-639, 2009. ,
DOI : 10.4049/jimmunol.164.12.6230